Navigate this market better. Subscribe for FREE stock alerts and information.

Monday, February 13, 2012

Express Scripts, Medco respond to FTC on deal, (NASDAQ: ESRX)

Pharmacy benefit managers Express Scripts Inc and Medco Health Solutions Inc have supplied more information requested by U.S. antitrust regulators in connection with their pending $29 billion merger, Medco said on Monday. The companies complied with a so-called "second request" for information from the Federal Trade Commission, Medco said in a securities filing. Such a second request for information is frequently made when potential competitive issues exist on a deal.

Express Scripts, Inc. is a pharmacy benefit management (PBM) operating in North America, offering a range of services to its clients, which include health maintenance organizations (HMOs), health insurers, third-party administrators, employers, union-sponsored benefit plans, workers? compensation plans and Government health programs. Shares of ESRX remained unchanged at $50.17. In the past year, the shares have traded as low as $34.47 and as high as $60.89. On average, 6636800 shares of ESRX exchange hands on a given day and today's volume is recorded at 0.



Source